Corbus Pharmaceuticals Holdings, INC. (CRBP) — 8-K Filings

8-K Filings (22)

• 8-K Filing — Apr 7, 2026
• Corbus Pharma Reports Director/Officer Changes & Compensation — Dec 18, 2025 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on December 18, 2025, reporting on events as of December 12, 2025. The filing covers the departure of directo
• 8-K Filing — Dec 11, 2025
• Corbus Pharmaceuticals Files 8-K on Financials — Nov 12, 2025 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on November 12, 2025, reporting on its results of operations and financial condition. The filing also include
• 8-K Filing — Nov 3, 2025
• Corbus Pharmaceuticals Files 8-K — Oct 30, 2025 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on October 30, 2025, to report on other events. The filing does not contain specific details about the nature
• Corbus Pharmaceuticals Files 8-K — Oct 20, 2025 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on October 20, 2025, reporting events as of October 18, 2025. The filing includes information related to Regu
• Corbus Pharmaceuticals Files 8-K — Sep 16, 2025 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on September 16, 2025, reporting on various events. The filing includes information related to Regulation FD
• Corbus Pharmaceuticals Files 8-K on Shareholder Vote & Other Events — May 19, 2025 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on May 19, 2025, reporting on matters submitted to a vote of security holders and other events that occurred
• Corbus Pharma Reports Director/Officer Changes — Mar 21, 2025 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on March 21, 2025, reporting changes effective March 20, 2025. The filing covers the departure of directors o
• Corbus Pharma Reports Director/Officer Changes & Financials — Mar 18, 2025 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on March 18, 2025, reporting on events as of March 13, 2025. The filing covers the departure of directors or
• Corbus Pharmaceuticals Files 8-K — Feb 14, 2025 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on February 14, 2025, reporting its status as a publicly traded company. The filing confirms its principal ex
• Corbus Pharmaceuticals Files 8-K — Dec 3, 2024 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on December 3, 2024, to report on various events. The filing includes information related to Regulation FD di
• Corbus Pharmaceuticals Files 8-K — Nov 15, 2024 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on November 15, 2024, reporting an "Other Event." The filing does not contain specific details about the even
• Corbus Pharmaceuticals Files 8-K — Nov 4, 2024 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on November 4, 2024, reporting its corporate information. The company is incorporated in Delaware and its pri
• KKR to Acquire Corbus Pharmaceuticals for $335M — Sep 3, 2024 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. announced on August 29, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of KKR & Co.
• Corbus Pharma Reports Director/Officer Changes & Compensation — Aug 20, 2024 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on August 20, 2024, reporting events as of August 15, 2024. The filing primarily concerns the departure of di
• KKR to Acquire Corbus Pharmaceuticals — Jun 17, 2024 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. announced on June 14, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of KKR & Co. In
• 8-K Filing — Jun 3, 2024
• Corbus Pharma Reports Director/Officer Changes & Shareholder Votes — May 20, 2024 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on May 20, 2024, reporting events as of May 16, 2024. The filing indicates changes related to the departure o
• KKR to Acquire Corbus Pharmaceuticals for $3.00/Share — May 9, 2024 Risk: medium
  Corbus Pharmaceuticals Holdings, Inc. announced on May 9, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of KKR & Co. Inc.
• Corbus Pharma Reports Director Changes & Financials — Apr 10, 2024 Risk: low
  Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on April 10, 2024, reporting on the departure of directors, election of new directors, appointment of officer

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX